m+Medelevator.RU
← Поиск публикаций
EFSA journal. European Food Safety Authority · 2026

Assessment of the feed additive consisting of Lactiplantibacillus plantarumNCIMB 30238 and Pediococcus pentosaceusNCIMB 30237 (1k21008) for all animal species for the renewal of its authorisation (Volac International Ltd).

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa Roberto Edoardo, Azimonti Giovanna, Bonos Eleftherios, Christensen Henrik, Durjava Mojca, Dusemund Birgit, Gehring Ronette, Glandorf Boet, Kouba Maryline, López-Alonso Marta, Marcon Francesca, Martelli Giovanna, Nebbia Carlo, Pechová Alena, Prieto-Maradona Miguel, Theodoridou Katerina, Anguita Montserrat, Brozzi Rosella, Bozzi Cionci Nicole, Innocenti Matteo L, Revez Joana

Аннотация

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of authorisation of a preparation of Lactiplantibacillus plantarum NCIMB 30238 and Pediococcus pentosaceus NCIMB 30237 (1k21008) as a technological additive to improve ensiling of fresh material for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. There is no new evidence that would lead the FEEDAP Panel to reconsider its previous conclusions. Thus, the Panel concludes that the additive remains safe for all animal species, consumers and the environment. Regarding the user safety, the additive should be considered as a skin sensitiser, but no conclusions can be drawn on the skin sensitisation. No conclusions can be drawn on the eye irritation potential of the additive. Exposure of users by dermal and respiratory routes is considered a risk. There is no need for assessing the efficacy of the additive in the context of renewal of the authorisation.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты